Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Knox

Showing results (671-680 of 829) with videos related to

Pageof 83
Sort By:
Clinical Oncology (Royal College of Radiologists (Great Britain))|November 15, 2006
Transarterial chemoembolisation for advanced hepatocellular carcinoma: results from a North American cancer centreM Molinari, J R Kachura, E Dixon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 21, 2008
Phase II trial evaluating the clinical and biologic effects of bevacizumab in unresectable hepatocellular carcinomaAbby B Siegel, Emil I Cohen, Allyson Ocean, et al.
Cancer Gene Therapy|July 1, 1997
Sensitization of colorectal and pancreatic cancer cell lines to the prodrug 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB1954) by retroviral transduction and expression of the E. coli nitroreductase geneN K Green, D J Youngs, J P Neoptolemos, et al.
Future Oncology (London, England)|November 24, 2025
LIVER-R study protocol: a global real-world study of durvalumab-based regimens in patients with hepatobiliary cancersMasafumi Ikeda, Marcus-Alexander Wörns, Mehmet Akce, et al.
The European Respiratory Journal|May 30, 2015
Pseudomonas aeruginosa quorum sensing molecules correlate with clinical status in cystic fibrosisHelen L Barr, Nigel Halliday, Miguel Cámara, et al.
Molecular Carcinogenesis|September 12, 2017
Two BRM promoter polymorphisms predict poor survival in patients with hepatocellular carcinomaIvan Pasic, Kit M Wong, Jonghun J Lee, et al.
Cancers|August 29, 2024
Real-World Outcomes of Atezolizumab with Bevacizumab Treatment in Hepatocellular Carcinoma Patients: Effectiveness, Esophagogastroduodenoscopy Utilization and Bleeding ComplicationsCha Len Lee, Mark Freeman, Kelly W Burak, et al.
Journal of Hepatology|December 3, 2014
Sofosbuvir plus ribavirin for the treatment of chronic genotype 4 hepatitis C virus infection in patients of Egyptian ancestryPeter J Ruane, Dani Ain, Richard Stryker, et al.
JCI Insight|April 20, 2017
T-bet+ B cells are induced by human viral infections and dominate the HIV gp140 responseJames J Knox, Marcus Buggert, Lela Kardava, et al.
Cancer|July 27, 2012
Phase 2 trial of linifanib (ABT-869) in patients with unresectable or metastatic hepatocellular carcinomaHan Chong Toh, Pei-Jer Chen, Brian I Carr, et al.
Pageof 83

Showing results (671-680 of 829) with videos related to

Sort By:
Pageof 83
Clinical Oncology (Royal College of Radiologists (Great Britain))|November 15, 2006
Transarterial chemoembolisation for advanced hepatocellular carcinoma: results from a North American cancer centreM Molinari, J R Kachura, E Dixon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 21, 2008
Phase II trial evaluating the clinical and biologic effects of bevacizumab in unresectable hepatocellular carcinomaAbby B Siegel, Emil I Cohen, Allyson Ocean, et al.
Cancer Gene Therapy|July 1, 1997
Sensitization of colorectal and pancreatic cancer cell lines to the prodrug 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB1954) by retroviral transduction and expression of the E. coli nitroreductase geneN K Green, D J Youngs, J P Neoptolemos, et al.
Future Oncology (London, England)|November 24, 2025
LIVER-R study protocol: a global real-world study of durvalumab-based regimens in patients with hepatobiliary cancersMasafumi Ikeda, Marcus-Alexander Wörns, Mehmet Akce, et al.
The European Respiratory Journal|May 30, 2015
Pseudomonas aeruginosa quorum sensing molecules correlate with clinical status in cystic fibrosisHelen L Barr, Nigel Halliday, Miguel Cámara, et al.
Molecular Carcinogenesis|September 12, 2017
Two BRM promoter polymorphisms predict poor survival in patients with hepatocellular carcinomaIvan Pasic, Kit M Wong, Jonghun J Lee, et al.
Cancers|August 29, 2024
Real-World Outcomes of Atezolizumab with Bevacizumab Treatment in Hepatocellular Carcinoma Patients: Effectiveness, Esophagogastroduodenoscopy Utilization and Bleeding ComplicationsCha Len Lee, Mark Freeman, Kelly W Burak, et al.
Journal of Hepatology|December 3, 2014
Sofosbuvir plus ribavirin for the treatment of chronic genotype 4 hepatitis C virus infection in patients of Egyptian ancestryPeter J Ruane, Dani Ain, Richard Stryker, et al.
JCI Insight|April 20, 2017
T-bet+ B cells are induced by human viral infections and dominate the HIV gp140 responseJames J Knox, Marcus Buggert, Lela Kardava, et al.
Cancer|July 27, 2012
Phase 2 trial of linifanib (ABT-869) in patients with unresectable or metastatic hepatocellular carcinomaHan Chong Toh, Pei-Jer Chen, Brian I Carr, et al.
Pageof 83